The findings demonstrated that high IFITM2 expression in CRC was markedly related to the tumor N (OR = 1.396 for N0 vs. N1 and N2), M (OR = 1.625 for M0 vs. M1), and pathologic stages (OR = 1.413 for stage I vs. stage II, stage III, and stage IV) (all p < 0.05; Table 2). This evidence concerns the gene IFITM2 and colorectal carcinoma.